109906
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
贝伐单抗在复发性鼻眶血管瘤中的应用：个案报告
Authors Liu S , Zhao H , Shi L , Ji H
Received 12 June 2024
Accepted for publication 19 October 2024
Published 24 October 2024 Volume 2024:18 Pages 307—311
DOI https://doi.org/10.2147/BTT.S482138
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Shein-Chung Chow
摘要： 鼻眶血管瘤是一种常见的成人良性眶内病变，复发性病例在传统手术治疗后仍面临较高的复发风险及并发症。本报告介绍了一例21岁男性患者，先后接受多次手术治疗后血管瘤复发，且伴随严重鼻出血，手术已无法进一步控制病情。采用抗血管生成药物贝伐单抗进行非手术治疗，显著缩小了肿瘤，并有效控制了症状。经过两年的随访观察，患者肿瘤未出现复发，且无严重不良反应。本案例表明，贝伐单抗可作为复发性鼻眶血管瘤的一种安全且有效的非手术治疗选择，为该类难治性血管瘤的治疗提供了新的方向。